ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15,139,182 | +23.3% | 373,254 | +0.4% | 0.55% | +17.0% |
| Q3 2022 | $12,282,000 | -4.0% | 371,623 | +2.3% | 0.47% | -7.7% |
| Q2 2022 | $12,795,000 | -19.4% | 363,379 | +5.3% | 0.51% | -3.4% |
| Q1 2022 | $15,870,000 | -29.2% | 345,085 | +2.0% | 0.53% | -21.5% |
| Q4 2021 | $22,421,000 | +6.0% | 338,171 | -0.2% | 0.67% | +2.6% |
| Q3 2021 | $21,147,000 | -27.5% | 338,734 | -3.8% | 0.65% | -24.7% |
| Q2 2021 | $29,160,000 | +23.2% | 352,089 | -1.4% | 0.87% | +13.9% |
| Q1 2021 | $23,678,000 | -21.5% | 357,082 | -9.2% | 0.76% | -23.7% |
| Q4 2020 | $30,175,000 | +81.9% | 393,263 | +2.1% | 1.00% | +38.8% |
| Q3 2020 | $16,589,000 | -9.4% | 385,259 | -9.2% | 0.72% | -12.3% |
| Q2 2020 | $18,318,000 | – | 424,128 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |